These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7259814)

  • 21. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
    McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with slow release oxprenolol alone, or in combination with other drugs: effects on blood pressure, lipoproteins and exercise performance.
    Simons LA; England JD; Balasubramaniam S; Viles L
    Aust N Z J Med; 1982 Dec; 12(6):612-6. PubMed ID: 6962709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
    Forrest WA
    J Int Med Res; 1980; 8(2):127-31. PubMed ID: 6102939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.
    McVeigh GE; McMaster M; Linton T; Whitehead E; Johnston GD
    Eur J Clin Pharmacol; 1990; 38(4):351-7. PubMed ID: 2188845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients.
    Waal-Manning HJ
    Clin Exp Pharmacol Physiol; 1975; 2(2):141-6. PubMed ID: 1095262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazides, beta blockers and lipoproteins.
    Ballantyne D; Ballantyne FC
    Postgrad Med J; 1983 Aug; 59(694):483-8. PubMed ID: 6137813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antihypertensive therapy and lipid metabolism].
    Krone W; Müller-Wieland D; Greten H
    Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperkalaemia and overdose of antihypertensive agents.
    Hume L; Forfar JC
    Lancet; 1977 Dec; 2(8049):1182. PubMed ID: 73096
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperkalaemia and overdose of antihypertensive agents.
    Nawar T
    Lancet; 1978 Apr; 1(8066):717. PubMed ID: 76255
    [No Abstract]   [Full Text] [Related]  

  • 31. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL; Metcalfe J; Simpson CN
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.
    West MJ; Kendall MJ; Mitchard M; Faragher EB
    Br J Clin Pharmacol; 1976 Jun; 3(3):439-43. PubMed ID: 788749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y; Gagné C
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once daily beta-blocker in hypertension--oxprenolol slow-release.
    Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
    J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of cystamine on the diuretic effect of uragogic agents].
    Nikitin AI; Samoĭlov LV
    Farmakol Toksikol; 1978; 41(2):193-6. PubMed ID: 658364
    [No Abstract]   [Full Text] [Related]  

  • 37. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP; Whitehead EM; Crawford V; McVeigh GE; Johnston GD
    Q J Med; 1991 Nov; 81(295):919-28. PubMed ID: 1808632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antihypertensive agents on lipid metabolism.
    Cutler R
    Am J Cardiol; 1983 Feb; 51(4):628-31. PubMed ID: 6131603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.